Ranked #1
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
Many listeners may be familiar with the FDA's Adverse Event Reporting System or FAERS. Data in FAERS supports the FDA's ... Read more
29 Oct 2017
•
Ranked #2
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle ce... Read more
17 Aug 2017
•
Ranked #3
Pinpointing the Top Questions about Biosimilars in Rheumatology
Pinpointing the Top Questions about Biosimilars in Rheumatology
Guest: Leonard H. Calabrese, DO Guest: John R. Tesser, MD This activity provides patient and practice-specific bios... Read more
30 Nov 2017
•
Ranked #4
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer
FDA medical oncologists discuss the agency’s accelerated approval of rucaparib for treatment of patients with deleteriou... Read more
17 May 2017
•
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ranked #5
FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin
FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin
Based on new data from two large clinical trials, the FDA concluded that the type 2 diabetes medicine canagliflozin (bra... Read more
16 May 2017
•
Ranked #6
Introducing FDA's Drug Information Soundcast in Clinical Oncology (DISCO)
Introducing FDA's Drug Information Soundcast in Clinical Oncology (DISCO)
In the FDA's inaugural Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) episode, Dr. Richard Pazdur, directo... Read more
16 May 2017
•
Ranked #7
FDA Restricts Use of Prescription Codeine and Tramadol Pain Medicines in Children
FDA Restricts Use of Prescription Codeine and Tramadol Pain Medicines in Children
The Food and Drug Administration (FDA) is restricting the use of codeine and tramadol medicines in children. Codeine is ... Read more
20 Apr 2017
•
Ranked #8
New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)
New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)
FDA is recommending new safety measures to improve the safe use of long acting beta agonists (LABAs).
23 Feb 2010
•
Ranked #9
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
The FDA has made strides in improving transparency and data access, and has implemented tools to allow the pharmaceutica... Read more
31 Jul 2018
•
Ranked #10
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar diso... Read more
4 May 2018
•
